Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies (Q40283103)

19 September 2017

Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies (English)

1 reference

19 September 2017

Orthoebolavirus zairense

0 references

1 reference

0 references

1 reference

Michael Lo

5

0 references

Richard W. Compans

object named as

Richard W Compans

9

0 references

Bali Pulendran

8

object named as

Bali Pulendran

1 reference

19 September 2017

Ling Ye

1

1 reference

19 September 2017

Jianguo Lin

2

1 reference

19 September 2017

Yuliang Sun

3

1 reference

19 September 2017

Soumaya Bennouna

4

1 reference

19 September 2017

Qingyang Wu

6

1 reference

19 September 2017

Zhigao Bu

7

1 reference

19 September 2017

Chinglai Yang

10

1 reference

19 September 2017

language of work or name

English

0 references

publication date

4 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

351

1 reference

19 September 2017

2

1 reference

19 September 2017

260-270

1 reference

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

The influence of virus structure on antibody responses and virus serotype formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

The influence of antigen organization on B cell responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Hemorrhagic fever viruses as biological weapons: medical and public health management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola protein analyses for the determination of genetic organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

New Vaccine and Treatment Excite Ebola Researchers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola virus: from discovery to vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Towards a vaccine against Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Exotic emerging viral diseases: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Vaccine research efforts for filoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola virus VP40-induced particle formation and association with the lipid bilayer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Vaccine for AIDS and Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Interleukin-10 and related cytokines and receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Ebola virus-like particles protect from lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Antibody neutralization and escape by HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Virus-like particle and DNA-based candidate AIDS vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

Expression and self-assembly of empty virus-like particles of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.021

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.03.021

1 reference

19 September 2017

1 reference